TipRanks
Go Ultimate55% OFF

Arcus Biosciences (RCUS) Revenue

Arcus Biosciences Revenue

Arcus Biosciences had a revenue of 41.00M in the quarter ending Jun 30, 2026, with 141.18%. This bring the company's revenue in the last twelve months to 117.00M, Decreased 50.42%. In the fiscal year ending Dec 31, 2025, Arcus Biosciences had annual revenue of 247.00M with -4.26% growth.

Revenue (ttm)
117.00M
Revenue Growth
-55.34%
P/S Ratio
10.43
Revenue/Employee
$410,982
Employees
601
Market Cap
$2.58B

Revenue Chart

Arcus Biosciences Revenue - Annual

0100M200M300M400M500M1.41M8.35M15.00M78.00M383.00M112.00M117.00M258.00M247.00M201720182019202020212022202320242025
Revenue History
Download to Excel
RCUS revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 2025247.00M-11.00M-4.26%
Dec 31, 2024258.00M141.00M120.51%
Dec 31, 2023117.00M5.00M4.46%
Dec 31, 2022112.00M-271.00M-70.76%
Dec 31, 2021383.00M305.00M391.03%
Dec 31, 202078.00M63.00M420.00%
Dec 31, 201915.00M6.65M79.58%
Dec 31, 20188.35M6.94M491.15%
Dec 31, 20171.41M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
RCUS117.00M
XNCR104.97M
CRSP13.39M
LEGN1.27B
NRIX701.94M
IMCR403.72M